Trump administration nixes plan to cover anti-obesity drugs through Medicare

Latest Stories from The Associated Press - Een podcast door The Associated Press - Zaterdagen

Podcast artwork

The Trump’s administration has decided not to cover costly injectable drugs for obesity, under Medicare’s Part D prescription drug program. The AP's Jennifer King has more.

Visit the podcast's native language site